Yasuto Itoyama
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.
Journal: Brain : a journal of neurology
Published: August 08, 2020
Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
Journal: Journal of neuroinflammation
Published: January 08, 2018
Perceptions regarding a range of work-related issues and corresponding support needs of individuals with an intractable disease.
Journal: Intractable & rare diseases research
Published: September 28, 2016
Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study.
Journal: BMC neurology
Published: July 19, 2016
Impact of the Great East Japan Earthquake in 2011 on MS and NMOSD: a study in Sendai, Japan.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 01, 2016
Complement-dependent and -independent aquaporin 4-antibody-mediated cytotoxicity in human astrocytes: Pathogenetic implications in neuromyelitis optica.
Journal: Biochemistry and biophysics reports
Published: March 06, 2016
FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion.
Journal: Journal of human genetics
Published: October 27, 2015
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: October 07, 2014
The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
Journal: Brain pathology (Zurich, Switzerland)
Published: October 23, 2013
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Journal: Neurology
Published: May 17, 2013
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Journal: BMC neurology
Published: April 18, 2013
Last Updated: 09/26/2026